PRINTER'S NO. 3255
No. 2251 Session of 2008
INTRODUCED BY DeLUCA, McILHATTAN, THOMAS, GINGRICH, MUNDY, BIANCUCCI, CALTAGIRONE, CASORIO, COHEN, CURRY, DePASQUALE, DERMODY, EACHUS, FABRIZIO, FRANKEL, FREEMAN, GALLOWAY, GEORGE, GIBBONS, GOODMAN, GRUCELA, HARKINS, HENNESSEY, JOSEPHS, KOTIK, LONGIETTI, MANDERINO, MARKOSEK, McGEEHAN, MELIO, MILNE, M. O'BRIEN, PASHINSKI, PETRARCA, PETRONE, PYLE, READSHAW, REED, REICHLEY, SURRA, WALKO, WANSACZ, J. WHITE, YOUNGBLOOD AND YUDICHAK, FEBRUARY 14, 2008
REFERRED TO COMMITTEE ON INSURANCE, FEBRUARY 14, 2008
AN ACT 1 Establishing One Pennsylvania, a program to consolidate and 2 unify procedures and requirements for the administration of 3 all Commonwealth-funded, Commonwealth-administered and 4 Commonwealth-supported prescription drug programs and for 5 reimbursement for pharmaceutical services. 6 The General Assembly of the Commonwealth of Pennsylvania 7 hereby enacts as follows: 8 Section 1. Short title. 9 This act shall be known and may be cited as the One 10 Pennsylvania Act. 11 Section 2. Definitions. 12 The following words and phrases when used in this act shall 13 have the meanings given to them in this section unless the 14 context clearly indicates otherwise: 15 "Adjudication." 16 (1) Except as provided in paragraph (2), an action taken
1 by the Office of Administration, the Secretary of 2 Administration or a prescription drug plan pursuant to this 3 act that constitutes an adjudication as defined by 2 Pa.C.S. 4 § 101 (relating to definitions), including any of the 5 following: 6 (i) A decision to allow a provider to participate in 7 a prescription drug plan or to suspend, restrict or 8 revoke participation by a provider in a prescription drug 9 plan. 10 (ii) A decision by the Office of Administration to 11 include or exclude a medication from the formulary or 12 preferred drug list. 13 (iii) The establishment of provider reimbursement 14 rates and formulas. 15 (iv) A decision to grant or deny prior authorization 16 for the dispensing of prescription drugs or to approve or 17 disapprove the dispensing of drugs not included on the 18 formulary or preferred drug list. 19 (v) An action taken by the program based upon audits 20 of claims submitted for reimbursement by providers. 21 (2) An action taken by the program with respect to 22 determining recipient eligibility shall not be deemed an 23 adjudication by the Office of Administration pursuant to its 24 authority under this act. Eligibility shall be determined by 25 the agency or entity under whose authority the prescription 26 drug plan is authorized. 27 "Alerts." Electronic communications between the Office of 28 Administration or the pharmacy benefits consolidation program 29 and pharmacies providing information pertaining to the 30 implementation of this act, including any of the following: 20080H2251B3255 - 2 -
1 (1) Information regarding the preferred drug lists. 2 (2) Preferred drug lists. 3 (3) Drug utilization review. 4 (4) Prior authorization. 5 (5) Disease management programs. 6 (6) Claims submission and adjudication procedures. 7 (7) Audits. 8 (8) Pharmacy and patient education. 9 "Best price." As defined under section 1927(c) of the Social 10 Security Act (49 Stat. 620, 42 U.S.C. § 1396r-8(c)). 11 "Medical assistance program." The program established 12 pursuant to Subarticle (f) of Article IV of the act of June 13, 13 1967 (P.L.31, No.21), known as the Public Welfare Code. 14 "Medicare recipient." An individual residing in this 15 Commonwealth who receives benefits under Part A of Subchapter 16 XVIII of Chapter 7 of the Social Security Act (49 Stat. 620, 42 17 U.S.C. § 301 et seq.) or who is enrolled under Part B, C or D of 18 Subchapter XVIII. 19 "Office of Administration." The Office of Administration of 20 the Commonwealth. 21 "Pharmaceutical manufacturer." A manufacturer as defined by 22 section 1927(k)(5) of the Social Security Act (49 Stat. 620, 42 23 U.S.C. § 1396r-8(k)(5)). 24 "Pharmacy." A pharmacy licensed pursuant to the act of 25 September 27, 1961 (P.L.1700, No.699), known as the Pharmacy 26 Act. 27 "Pharmacy Act." The act of September 27, 1961 (P.L.1700, 28 No.699), known as the Pharmacy Act. 29 "Pharmacy services." The provision of health care services 30 defined as the practice of pharmacy by the act of September 27, 20080H2251B3255 - 3 -
1 1961 (P.L.1700, No.699), known as the Pharmacy Act. 2 "Preferred drug list." A list of prescription medications 3 covered under a prescription drug plan that may be dispensed by 4 a prescription drug plan without prior authorization, subject to 5 applicable limits and conditions. 6 "Prescription drug." A covered outpatient drug as defined by 7 section 1927(k)(2) of the Social Security Act (49 Stat. 620, 42 8 U.S.C. § 1396r-8(k)(2)). 9 "Prescription drug plan." A Commonwealth operation or funded 10 pharmaceutical program that pays or reimburses for prescription 11 drugs dispensed to individuals enrolled in the program that is 12 supported directly or indirectly, in whole or in part, by 13 Commonwealth public funds, including, but not limited to, all of 14 the following: 15 (1) The medical assistance program, the Special 16 Pharmaceutical Benefit Program in the Department of Public 17 Welfare. 18 (2) The Pharmaceutical Assistance Contract for the 19 Elderly (PACE) and any other pharmacy program administered by 20 the Commonwealth that is recognized by the Centers for 21 Medicare and Medicaid of the United States as a State 22 pharmaceutical assistance program. 23 (3) Programs or plans paying for prescription drugs 24 dispensed to employees as a retirement or employee benefit, 25 including programs established by the Public School 26 Employees' Retirement System, the State Employees' Retirement 27 System and the State Employees' Benefit Trust Fund. 28 (4) A pharmaceutical program that utilizes funds of this 29 Commonwealth, including the State Lottery Fund, to provide 30 assistance in obtaining prescription drugs to Medicare 20080H2251B3255 - 4 -
1 recipients. 2 (5) Programs where the Commonwealth purchases or 3 reimburses affiliates or designees for a pharmaceutical drug 4 benefit. The programs shall include the Children's Health 5 Insurance Program, Workers' Compensation Program and any 6 program involving the purchase or reimbursement of 7 pharmaceutical drugs for inmates under the Department of 8 Corrections. 9 (6) The End Stage Renal Program in the Department of 10 Health. 11 (7) All prescription drug plans that prescribe benefits 12 to members and employees of the General Assembly and the 13 unified judicial system and its retirees. 14 "Program." The One Pennsylvania pharmacy benefits 15 consolidation program established pursuant to section 3. 16 "Provider." A pharmacy, a dispensing physician or a 17 certified registered nurse practitioner enrolled as a provider 18 in the One Pennsylvania program. 19 "Public School Employees' Retirement System." The retirement 20 system established by 24 Pa.C.S. Part IV (relating to retirement 21 for school employees). 22 "Public Welfare Code." The act of June 13, 1967 (P.L.31, 23 No.21), known as the Public Welfare Code. 24 "Retail pharmacy." A pharmacy licensed to operate pursuant 25 to the act of September 27, 1961 (P.L.1700, No.699), known as 26 the Pharmacy Act, which provides services to the general public, 27 excluding any institutional pharmacy, specialty pharmacy or 28 mail-order pharmacy. 29 "Secretary." The Secretary of Administration of the 30 Commonwealth. 20080H2251B3255 - 5 -
1 "Social Security Act." The Social Security Act (49 Stat. 2 620, 42 U.S.C. § 301 et seq.). A reference to the Social 3 Security Act shall include regulations implementing the Social 4 Security Act adopted by the United States Department of Health 5 and Human Services or the Centers for Medicare and Medicaid 6 Services. 7 "State agency." Any of the following entities that purchases 8 or provides coverage for prescription medications: 9 (1) An agency under the jurisdiction of the Governor. 10 (2) An independent agency supported by public funds. 11 "State Employees' Benefit Trust Fund." The trust fund 12 established to purchase health insurance coverage, including 13 coverage for prescription medications, for State employees. 14 "State Employees' Retirement System." The retirement system 15 established under 71 Pa.C.S. Part XXV (relating to retirement 16 for State employees and officers). 17 Section 3. One Pennsylvania. 18 (a) Establishment.--The Office of Administration shall 19 establish a pharmacy benefits consolidation program to be known 20 as One Pennsylvania. The program shall administer all publicly 21 funded Commonwealth prescription drug plans through an 22 integrated system of plan administration using uniform standards 23 and requirements for the reimbursement to providers as provided 24 by this act. 25 (b) Program requirements.--The Office of Administration 26 shall do all of the following: 27 (1) Develop, manage and implement preferred drug lists 28 for all publicly funded Commonwealth prescription drug plans 29 to the extent allowed by applicable Federal law. A preferred 30 drug list shall include all prescription drugs for which a 20080H2251B3255 - 6 -
1 manufacturer has entered into a rebate agreement pursuant to 2 section 6 and the requirements and restrictions, except for 3 prior authorization, provided by section 1927(d) of the 4 Social Security Act. A preferred drug list shall comply with 5 the standards established by Part D, section 1860D-4(b)(3) of 6 the Social Security Act and any additional regulations as may 7 be adopted by the Office of Administration pursuant to this 8 act. A current list of drugs included in the preferred drug 9 list shall be publicly available, posted electronically on 10 the Internet website of the Office of Administration and 11 communicated to pharmacies through alerts. All preferred drug 12 lists shall be uniform to the extent administratively 13 feasible under the statutory authority establishing the 14 individual prescription drug plans. The Office of 15 Administration may, in its discretion, allow exceptions to 16 the uniformity requirements in administrating the individual 17 programs due to fiscal and administrative considerations. 18 (2) Adopt regulations relating to the eligibility of 19 participating providers and the adjudication of items and all 20 other provisions necessary to carry out the provisions of 21 this act. Any pharmacy shall be eligible to participate in 22 the program, provided the pharmacy complies with the 23 regulations adopted under the paragraph and other provisions 24 of this act. 25 (3) The Office of Administration shall promulgate 26 statements of policy, as necessary, to carry out the 27 provisions of this act. No statement of this policy adopted 28 by the Office of Administration shall have the force and 29 effect of law or regulation or may modify the provisions of 30 any regulations adopted by the Office of Administration. All 20080H2251B3255 - 7 -
1 statements of policy adopted by the Office of Administration 2 shall, except in emergency circumstances, be published for 3 notice and comment prior to adoption and shall be published 4 in the Pennsylvania Bulletin. 5 (4) (i) Except as provided in subparagraph (ii), make 6 provisions for generic substitutions in accordance with 7 the act of November 24, 1976 (P.L.1163, No.259), referred 8 to as the Generic Equivalent Drug Law. 9 (ii) Notwithstanding the provisions of the Generic 10 Equivalent Drug Law and the act of August 26, 1971 11 (P.L.351, No.91), known as the State Lottery Law, generic 12 substitutions shall only be dispensed when it is less 13 expensive for the program. 14 (5) Provide for a program of prospective drug 15 utilization review consistent with section 1927(g)(2) of the 16 Social Security Act. 17 (6) Provide for prior authorization consistent with the 18 requirements of section 1927(g)(5)of the Social Security Act 19 and in accordance with regulations of the Office of 20 Administration. 21 (7) Provide for a program of retrospective drug 22 utilization review and education consistent with section 23 1927(g)(2) of the Social Security Act and in accordance with 24 regulations of the Office of Administration to ensure that 25 prescriptions are appropriate, medically necessary and not 26 likely to result in adverse medical results and to educate 27 providers and recipients of pharmacy services through the 28 pharmacy consolidated benefits program and to correct and 29 report misutilization and abuse by licensed prescribers and 30 recipients and provide for fraud and abuse audits, 20080H2251B3255 - 8 -
1 coordinating its activities with the secretary to support 2 compliance with applicable laws and regulations. Pharmacies 3 shall not be denied payments for medications dispensed based 4 upon the results of retrospective drug utilization review or 5 audits, where the medication was dispensed in good faith by 6 the pharmacy without prior knowledge that the prescription of 7 a medication was not appropriate or necessary, was likely to 8 cause adverse medical results or constituted a fraudulent or 9 abusive practice by the prescriber. 10 (8) Establish a program of medication therapy management 11 consistent with section 1860D-4(c)(2) of the Social Security 12 Act. 13 (9) Provide educational materials for program recipients 14 of pharmacy services on disease and care management. 15 (10) In accordance with section 1927(a) through (d) of 16 the Social Security Act or Chapter 7 of the act of August 26, 17 1971 (P.L.351, No.91), known as the State Lottery Law, bill, 18 recoup and relay to the medical assistance program 19 manufacturers' drug rebates and excessive consumer price 20 inflation discounts and resolve disputes. Upon the 21 establishment of the program, all medical assistance 22 recipients shall be enrolled in prescription drug programs 23 for which rebates and discounts are collected pursuant to 24 section 1927(a) through (d) of the Social Security Act. 25 (11) Adjudicate claims through an electronic claims 26 management system consistent with section 1927(h) of the 27 Social Security Act and which allows for an emergency supply 28 of prescribed medication in the event of equipment failures. 29 (12) The Office of Administration shall develop a manual 30 setting forth procedures, guidelines and standards to be 20080H2251B3255 - 9 -
1 utilized by prescription drug plans in audits of providers 2 pertaining to the program. 3 (13) Create a uniform audit and recoupment system 4 subject to the requirements of section 7(c) for all of the 5 following: 6 (i) Pharmacies, pharmacists, dispensing physicians 7 and any other providers under this act. 8 (ii) Pharmaceutical manufacturers, wholesalers and 9 other suppliers of prescription drugs. 10 (14) Provide for the reimbursement of all providers 11 participating in prescription drug programs on a fee-for- 12 service basis. 13 (15) Allow providers certified in medication therapy 14 management by a national accrediting body or by any other 15 certification process approved by the State Board of Pharmacy 16 to provide medication therapy management. 17 (c) Considerations.--In preparing and managing the uniform 18 drug list, the Office of Administration shall enter into 19 agreements with drug manufacturers to collect and remit to the 20 program discounts, rebates or other concessions offered by 21 manufacturers. 22 (d) Advisory committee.-- 23 (1) An advisory committee for One Pennsylvania is 24 established to assist the program in making informed and 25 fiscally responsive decisions in administering and 26 consolidating the purchases and reimbursements of 27 pharmaceutical drugs and benefits for the Commonwealth. 28 (2) An advisory committee to the Office of 29 Administration shall consist of the following members: 30 (i) Three members appointed by the Governor. 20080H2251B3255 - 10 -
1 (ii) Two members appointed by each of the following: 2 (A) The President pro tempore of the Senate. 3 (B) The Minority Leader of the Senate. 4 (C) The Speaker of the House of Representatives. 5 (D) The Minority Leader of the House of 6 Representatives. 7 (3) Each legislative appointing authority shall appoint 8 one member pursuant to paragraph (1)(ii) involved in the 9 ownership or operation of independent pharmacies and one 10 member involved in the ownership or operation of chain 11 pharmacies. 12 (4) Members of the committee shall serve without 13 compensation but shall be reimbursed for their reasonable and 14 necessary expenses by the Office of Administration. 15 (5) Members of the committee shall serve for indefinite 16 terms at the will of their respective appointing authorities. 17 (6) Action by the committee shall require a vote by at 18 least seven members. 19 (7) Members of the committee shall annually elect a 20 chairperson. 21 (8) The advisory committee shall meet twice yearly to 22 provide advice and recommendations to the program in regard 23 to its policies and regulations. The advisory committee shall 24 review the audit manual and rebate agreement yearly and 25 develop recommendations to the Office of Administration as 26 needed. 27 Section 4. Reimbursement. 28 (a) General rule.--Reimbursement to providers shall include 29 all of the following: 30 (1) Payment sufficient to reimburse retail pharmacies 20080H2251B3255 - 11 -
1 for the reasonable and necessary costs incurred to purchase 2 drugs. 3 (2) Except to the extent otherwise required by Federal 4 law or regulations, payments to retail pharmacies pursuant to 5 paragraph (1) shall be based upon the average retail pharmacy 6 acquisition cost for a medication without regard to customary 7 prompt pay discounts in the package size most commonly 8 purchased by retail pharmacies as determined by the Office of 9 Administration pursuant to subsection (d), or a provider's 10 actual acquisition cost for a medication, whichever amount is 11 greater. 12 (3) Payment for dispensing costs adequate to cover costs 13 associated with all of the following: 14 (i) Wages and salaries. 15 (ii) Costs to store and secure inventory. 16 (iii) Patient counseling. 17 (iv) Drug utilization review. 18 (v) Licensing fees. 19 (vi) Taxes. 20 (vii) Insurance. 21 (viii) Other direct and indirect costs of operating 22 a pharmacy. 23 (ix) A reasonable profit to generate a return on the 24 investment associated with the costs. 25 (4) During the first year this section is in effect, 26 payments pursuant to paragraph (3) shall be not less than $10 27 for the dispensing of a single source drug as defined by 28 section 1927(k)(7)(A)(iv) of the Social Security Act or $15 29 for the dispensing of a multiple-source drug as defined by 30 section 1927(k)(7)(A)(iv) of the Social Security Act. 20080H2251B3255 - 12 -
1 Beginning on January 1 of each subsequent year, payment 2 pursuant to paragraph (3) shall be not less than the prior 3 year's minimum payments as adjusted based upon the annual 4 percentage change in Consumer Price Index for medical care 5 professional services as published by the Bureau of Labor 6 Statistics of the United States Department of Labor for the 7 month of December of the immediately prior year. 8 (5) Additional payment for: 9 (i) Medication therapy management. 10 (ii) Concurrent and retrospective utilization 11 review. 12 (iii) Managing prior authorization requirements. 13 (iv) To the extent authorized by section 9.1 of the 14 Pharmacy Act, implementing drug therapy protocols. 15 (v) Compounding prescriptions. 16 (vi) Preparing specialized packaging for the 17 administration of medications in long-term care 18 facilities. 19 (vii) Preparing medications for intravenous 20 administration. 21 (viii) Other reasonable and necessary pharmacy 22 services. 23 (b) Prompt payment.--Providers shall be paid within 21 days 24 of the Office of Administration's receipt of appropriate 25 substantiation of the transaction. Providers shall be entitled 26 to interest at the rate provided by section 806 of the act of 27 April 9, 1929 (P.L.343, No.176), known as The Fiscal Code, for 28 any payment not made within the 21-day period. 29 (c) Average retail pharmacy acquisition costs.--The Office 30 of Administration shall determine and publicly make available 20080H2251B3255 - 13 -
1 through its Internet website the average retail pharmacy 2 acquisition cost for covered medications pursuant to regulations 3 approved by the advisory committee in a manner consistent with 4 the methodology used by the Congressional Budget Office in its 5 December 26, 2006, report to the Committee on Energy and 6 Commerce of the United States House of Representatives based 7 upon a survey of retail pharmacy wholesale invoices or through 8 the use of commercially available sources of information. 9 Average pharmacy acquisition costs shall be updated weekly. 10 (d) Copayments.--Except for services which are excluded 11 under the Commonwealth's medical assistance program, the Office 12 of Administration may require providers to collect a copayment 13 in an amount set by the program. To the extent a provider is 14 required by Federal or State law to dispense prescriptions to 15 persons unable to satisfy copayment obligations, the provider 16 shall be reimbursed for uncollected copayment amounts. The 17 Office of Administration shall neither require copayments from 18 beneficiaries nor deduct copayment amounts from provider 19 reimbursements for any particular classes of drugs or 20 prescription drug plan recipients to the extent there is good 21 cause to conclude that copayment requirements will result in 22 noncompliance with prescription drug treatment protocols and 23 will increase overall health care costs or result in imminent 24 and substantial risk of harm or injury to recipients or other 25 persons. Except to the extent prohibited by Federal law, the 26 Office of Administration may accept compensation for the purpose 27 of reducing or eliminating copayments from drug manufacturers, 28 distributors, health care plans or other persons or 29 organizations for the purpose of encouraging therapeutically 30 desirable compliance with prescription drug treatment protocols. 20080H2251B3255 - 14 -
1 Section 5. Deposit of funds. 2 A special fund is established in the State Treasury to be 3 known as the Special Pharmaceutical Fund. All moneys 4 appropriated from the State Lottery Fund for PACE operations 5 shall be deposited in the Special Pharmaceutical Fund. All 6 Federal moneys received by the Commonwealth per any 7 pharmaceutical program consolidated into One Pennsylvania under 8 this act shall be deposited in the Special Pharmaceutical Fund. 9 Any moneys appropriated from the General Fund for pharmaceutical 10 purchasing or reimbursement shall be deposited in this fund. All 11 rebates obtained through prudent pharmaceutical purchasing or 12 through rebate agreements shall be deposited. 13 Section 6. Rebate agreement. 14 (a) Required agreements.--Except as provided in subsection 15 (b), the Office of Administration shall not include on the 16 formulary of preferred drug list established pursuant to section 17 3(b)(1) any prescription drug unless the Office of 18 Administration and the pharmaceutical manufacturer have entered 19 into a rebate agreement covering that prescription drug on terms 20 comparable to agreements executed pursuant to section 1927(a), 21 (b), (c) and (d) of the Social Security Act. The rebate 22 agreement shall provide that, unless prohibited by Federal law, 23 the rebate shall be based on the best price and that additional 24 rebates shall be paid if the pharmaceutical manufacturer 25 increases the price of the drug by an amount greater than the 26 increase in the Consumer Price Index for All Urban Consumers. 27 Nothing in this act shall prevent the Office of Administration 28 from negotiating agreements for the payment of additional 29 rebates and discounts for the benefit of the medical assistance 30 program or from entering into rebate and discount agreements for 20080H2251B3255 - 15 -
1 other plans which have been consolidated into the program for 2 greater rebates and discounts than are required pursuant to 3 section 1927(c) of the Social Security Act. 4 (b) Exceptions.--Subsection (a) shall not apply if the 5 availability of the drug is essential to the health of members 6 of the pharmacy consolidated benefits program as determined by 7 the department. 8 (c) Contracts.--Pharmaceutical manufacturers must enter into 9 a rebate agreement with the department to obtain reimbursement 10 for prescription drugs included under this act. The rebate shall 11 be paid by the manufacturer not later than 30 days after the 12 date of receipt of information necessary to calculate the amount 13 of the rebate. The department shall have the authority to levy a 14 15% surcharge penalty on any rebate not in dispute that remains 15 unpaid for 90 or more days. 16 Section 7. Adjudications. 17 Adjudications conducted by the Office of Administration shall 18 be subject to 2 Pa.C.S. Ch. 5 Subch. A (relating to practice and 19 procedure of Commonwealth agencies) and Ch. 7 Subch. A (relating 20 to judicial review of Commonwealth agency action). The Office of 21 Administration shall adopt rules of procedure regarding the 22 conduct of adjudications involving pharmacies consistent with 23 the provisions of 67 Pa.C.S. §§ 1102 (relating to hearings 24 before the bureau), 1103 (relating to supersedeas), 1104 25 (relating to subpoenas) and 1105 (relating to determinations, 26 review, appeal and enforcement). 27 Section 8. Applicability. 28 This act shall apply to the medical assistance program except 29 to the extent the secretary, in consultation with the Secretary 30 of Public Welfare, determines that the application is a 20080H2251B3255 - 16 -
1 violation of Federal law or an existing contractual agreement. 2 Nothing in this act shall supersede or impede an existing 3 contractual agreement. Contractual agreements in effect on the 4 effective date of this section shall not be renewed or extended 5 to the extent inconsistent with the requirements of this act, 6 and the Office of Administration shall promptly enter into 7 negotiations to modify any contractual agreements inconsistent 8 with this act to conform to the requirements of this act. 9 Section 9. Prohibited activities. 10 It shall be unlawful for any individual, partnership or 11 corporation to solicit, receive, offer or pay any kickback, 12 bribe or rebate in cash or in kind from or to any person in 13 connection with the furnishing of services under this act to the 14 same extent as prohibited with respect to Federal health 15 programs by section 1128(b)(1) and (2) of the Social Security 16 Act, subject to the safe harbors from sanctions provided by 17 sections 1877(a)(1) and 1860D-4(e)(6) of the Social Security 18 Act. Violations of this section shall be subject to the 19 sanctions, penalties and remedies under section 1407 of the 20 Public Welfare Code. 21 Section 10. Repeals. 22 (a) Intent.--The General Assembly declares that the repeal 23 under subsection (b) is necessary to effectuate the purposes of 24 this act. 25 (b) Provision.--Section 509 of the act of August 26, 1971 26 (P.L.351, No.91), known as the State Lottery Law, is repealed. 27 (c) General.--All other acts and parts of acts are repealed 28 insofar as they are inconsistent with this act. 29 Section 11. Effective date. 30 This act shall take effect as follows: 20080H2251B3255 - 17 -
1 (1) Sections 3(d), 4(a)(4) and 6 shall take effect 2 immediately. 3 (2) The remainder of this act shall take effect in one 4 year. B11L35JKL/20080H2251B3255 - 18 -